EventsThe 1st International Online Conference on Diseases
Published
This submission belongs to the session S4. Geriatrics of the event The 1st International Online Conference on Diseases
Published date
03 Sep, 2025
Academic Editor
author-avatarMichele Malaguarnera
Citation
Mayra Alejandra Mafla-España, Maria Dolores Torregrosa-Maicas, Omar Cauli, Association between estrogen plasmatic levels and geriatric assessment in men with localized and metastatic prostate cancer, in Proceedings of The 1st International Online Conference on Diseases, 9 September–11 September 2025, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Association between estrogen plasmatic levels and geriatric assessment in men with localized and metastatic prostate cancer

Maria Dolores Torregrosa-Maicas 2
image
1. Department of Nursing, University of Valencia, 46010 Valencia, Spain, Spain
2. Department of Medicine, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain, Spain
Abstract

Authors: Mayra Alejandra Mafla España, Maria Dolores Torregrosa Maicas and Omar Cauli

Although the role of androgens in prostate cancer has been extensively investigated, the possible involvement of estrogens, such as estradiol and estrone, in the localized and metastatic stages of this disease remains little explored. The aim of this study was to analyze the association between plasma estradiol and estrone levels and different indicators of geriatric assessments in men diagnosed with prostate cancer, both in the localized and metastatic stages. Methods: We included 67 men with a confirmed diagnosis of prostate cancer, divided into two groups: 34 with localized disease and 33 with metastatic disease. The comprehensive geriatric assessment included evaluations of sleep quality (using the Athens Insomnia Scale), depressive symptoms (using the Yesavage Geriatric Depression Scale), cognitive function (using the Mini-Mental State Examination, MMSE) and perception of general health status. Results: In the metastatic group, statistically significant correlations were observed between estradiol levels and the Gleason index (Rho = 0.49, p = 0.03), the Charlson comorbidity index (Rho = 0.51, p = 0.01) and the subscale of the Athens Scale assessing difficulty sleeping through the night (Rho = -0.62, p = 0.003). No significant correlations were found between estrone levels and any of the parameters evaluated. In the group with localized disease, a significant correlation was found between estradiol levels and the Charlson index (Rho = -0.46; p = 0.02), with no associations observed with the other geriatric variables or with estrone levels. Conclusion: Estradiol shows relevant correlations with indicators of tumor progression, comorbidity and sleep quality in prostate cancer patients, particularly in the metastatic stage. These results suggest the need to deepen the potential role of estrogens in the clinical and geriatric context of this disease.

Keywords
Prostate cancer
estrone
estradiol
geriatric assessment
Oral Presentation
Pharmacological Therapy and Quality of Life in Rheumatoid Arthritis Patients from the North-East of Portugal: An Exploratory Study
Association between estrogen plasmatic levels and geriatric assessment in men with localized and metastatic prostate cancer